Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, discussed with HealthCentral two newly approved gene therapies for patients with the genetic blood disorder transfusion-dependent beta thalassemia.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Ajaykumar Rao Provides Perspective to HealthCentral on a New Program to Manage Type 2 Diabetes
Posted June 27, 2025Researchers have developed a new treatment program for type 2 diabetes, called GEM, which offers an individualized approach that teases out the few foods that spike blood sugar the most so patients can focus on reducing those foods without dieting.
Read MoreDr. Sara Keely Schultz Featured in HepCAP Video Celebrating Hepatitis Awareness Month
Posted June 27, 2025The Hepatitis C Allies of Philadelphia hosted an evening celebrating Hepatitis Awareness Month.
Read More